Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
Related Articles

News
Goeddel Family Technology Sandbox Named in Honor of $7.5M Gift from UC San Diego Alumnus
May 12, 2022
sandiegobiotech
News, UCSD News
Comments Off on Goeddel Family Technology Sandbox Named in Honor of $7.5M Gift from UC San Diego Alumnus
University of California San Diego alumnus David Goeddel, ’72, and his wife Alena, have donated $7.5 million to drive leading-edge research, discovery and training in the UC San Diego School of Biological Scienc… […]

News
Honoring the Class of 2020
On Friday, June 10, a special celebration was held to honor the achievements of the Class of 2020—the graduates who completed their degree as the COVID-19 pandemic began to sweep across the globe. More than 1,25… […]

News
U.S. News Names UC San Diego Graduate Programs Among Top 10 in Nation
March 29, 2022
sandiegobiotech
News, UCSD News
Comments Off on U.S. News Names UC San Diego Graduate Programs Among Top 10 in Nation
U.S. News & World Report today released its 2023 Best Graduate Schools rankings, naming graduate programs and professional schools at the University of California San Diego among the best in the country. The ran… […]